Best Options Strategy for BDTX
Looking for the best options strategy for Black Diamond Therapeutics, Inc. (BDTX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live BDTX option chain right now, and a simple map from your view on BDTX to the strategy that fits it. Model any of them in the calculator before you trade.
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics is a clinical-stage oncology company developing targeted therapies designed for tumors driven by specific genetic mutations. The company's pipeline centers on its MasterKey inhibitor platform, which aims to address hard-to-treat cancers with precision. Silevertinib, its most advanced candidate, crosses the blood-brain barrier and targets mutated EGFR; it is being tested in Phase 2 trials for EGFR-mutant lung cancer and glioblastoma. The company is also advancing BDTX-4933, a brain-penetrant RAF inhibitor in Phase 1 testing for solid tumors carrying KRAS, NRAS, or BRAF mutations. Additionally, BDTX-4876, which selectively targets oncogenic FGFR2 and FGFR3 mutations, remains in preclinical development.
Black Diamond generates value by advancing these drug candidates through the clinical trial process, with the ultimate goal of commercializing approved therapies. The company operates in the oncology market, which encompasses treatment options for genetically defined cancer subtypes. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond was previously known as ASET Therapeutics before rebranding in January 2018. As a clinical-stage…
Today's top-scoring strategy for BDTX
Our engine ranks defined-risk strategies on the live BDTX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $1.5 | $0.05 |
| Sell | 1× | PUT | $1.5 | $0.05 |
| Sell | 1× | CALL | $1.5 | $0.55 |
| Buy | 1× | CALL | $2.5 | $0.05 |
Simulazione
Simulazione prospettica di 6,000 traiettorie di prezzo lognormali fino alla scadenza — non è un backtest storico.
Analisi della strategia
Greche vs prezzo
Prezzo × volatilità (oggi)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $2 | −$5 | −$1 | $3 | $6 | $8 |
| $2 | −$1 | $2 | $5 | $8 | $10 |
| $2 | $3 | $6 | $8 | $10 | $12 |
| $2 | $7 | $9 | $11 | $13 | $14 |
| $2 | $11 | $12 | $14 | $15 | $17 |
| $2 | $15 | $16 | $16 | $18 | $19 |
| $2 | $19 | $19 | $19 | $20 | $21 |
| $2 | $23 | $22 | $22 | $23 | $23 |
| $2 | $27 | $26 | $25 | $25 | $26 |
| $1 | $31 | $29 | $28 | $28 | $28 |
| $1 | $35 | $33 | $31 | $31 | $30 |
Live scan from 2026-07-22 · quotes delayed ~15 minutes
Backtest storico: come si sarebbe comportata una Iron Butterfly su BDTX
Abbiamo simulato in modo approssimativo una Iron Butterfly su BDTX che avresti aperto ripetutamente nell'ultimo anno (93 ingressi storici, ciascuno mantenuto fino alla scadenza), con i premi d'ingresso modellati tramite Black-Scholes. Ecco come sarebbe andata sulla reale storia dei prezzi di BDTX — un backtest didattico, non una previsione dei rendimenti futuri.
In via approssimativa: i premi d'ingresso sono modellati con Black-Scholes sulla base della volatilità realizzata trailing, mantenuti fino alla scadenza e regolati contro il reale prezzo di chiusura storico. Fill reali, volatilità implicita e slippage differiscono — consideralo come contesto indicativo, non come rendimento esatto.
Implied volatility
BDTX is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 214% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on BDTX currently price in about 214% implied volatility, versus roughly 72% the stock has actually realised over the past month. That makes options relatively expensive — an edge for strategies that sell premium, such as credit spreads and iron condors.
Off that volatility, the options market is pricing a move of about ±$1,1 (±60%) in BDTX by 2026-08-21 — a range of roughly $0,72 to $2,93. Strikes inside that band hold most of the premium and see most of the action.
In evidenza dalla option chain di BDTX: open interest, volume e skew
La option chain live di BDTX mostra un rapporto put/call sull'open interest di 0.03 (bullish-leaning (more calls)), con una volatilità implicita at-the-money intorno al 155.1%. L'open interest si concentra sulla call a 2.5 — un classico "muro" di resistenza — e sulla put a 1.5, un "muro" di supporto: esattamente gli strike a cui gli scrittori di opzioni sono più esposti verso la scadenza.
Istantanea di open interest, volume e volatilità implicita per la scadenza scansionata più vicina — contesto, non un segnale di trading.
Earnings & IV crush
BDTX's next earnings report is due around 6 agosto 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
With earnings roughly 15 days out, BDTX's 214% implied volatility is inflated by event premium — and it usually collapses the moment results drop ("IV crush"). That rewards defined-risk premium sellers when the move stays muted, and punishes option buyers who paid the inflated price. Keep size small and risk defined through the report.
Key figures
- Market cap
- $105M
- Beta (vs market)
- 3.25
- 52-week range
- $1.60–$4.94 (7% up the range)
- Short interest
- 11.3% of float · 2.3 days to cover
With 11.3% of BDTX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for BDTX
Start with your outlook on BDTX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while BDTX stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open BDTX in the free calculator →
Domande frequenti
What is the best options strategy for BDTX?
It depends on your outlook. Bullish traders often use a long call or bull call spread on BDTX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are BDTX options liquid enough to trade?
Black Diamond Therapeutics, Inc. (BDTX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade BDTX options?
Buying a single BDTX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade BDTX or any security. Do your own research.
Cosa fa Black Diamond Therapeutics, Inc.?
Black Diamond Therapeutics, Inc. (BDTX) opera nel settore Biotechnology. La sezione "Informazioni su Black Diamond Therapeutics, Inc." qui sopra offre un quadro più completo di ciò che fa l'azienda e di come genera profitti.
Black Diamond Therapeutics, Inc. paga dividendi?
Qui non mostriamo un rendimento da dividendo confermato per Black Diamond Therapeutics, Inc., quindi consideralo incerto: prima di scrivere delle call controlla il dividendo attuale e la data di stacco cedola (ex-dividend) presso il tuo broker — una data di stacco imminente può innescare un'assegnazione anticipata sulle call scritte in-the-money.
Quando Black Diamond Therapeutics, Inc. pubblica gli utili?
I prossimi utili di Black Diamond Therapeutics, Inc. sono attesi intorno al 6 agosto 2026. La volatilità implicita di solito sale in avvicinamento alla pubblicazione e crolla bruscamente dopo (IV crush) — un aspetto importante per qualsiasi posizione in opzioni che mantieni oltre quella data.
Tickers related to BDTX
Comparing BDTX with similar names can help you choose the best options strategy:
Informazioni sull’azienda
- Sede
- 245 First Street, 18th Floor, Cambridge, MA, 02142, United States
- Settore
- Biotechnology
- Dipendenti
- 21
- CEO
- Dr. Mark A. Velleca M.D., Ph.D.
- Telefono
- 617 252 0848
- Sito web
- www.blackdiamondtherapeutics.com
Best Options Strategy by Ticker →
Solo per uso didattico. Le quotazioni sono ritardate di circa 15 minuti e nulla di ciò che è riportato qui è consulenza finanziaria. Il trading di opzioni comporta un rischio sostanziale di perdita. Privacy · Terms.